|
|
Editorials |
| Editorial
Why do patients with antiphospholipid antibody clot? |
351 |
| MD Lockshin
|
|
Full Article (PDF)
|
|
| Grand rounds from lupus centers–Edited by R Lahita
CLINICO-PATHOLOGICAL CONFERENCE |
353 |
| HM Moutsopoulos,
GS Hatzis & KG Avoni
|
|
Full Article (PDF)
|
|
Papers |
Effect of  2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system |
358 |
| T Atsumi,
MA Khamashta,
PRJ Ames,
K Ichikawa,
T Koike & GRV Hughes
|
|
Abstract
Full Article (PDF)
|
|
| Enhanced expression of nucleobindin in lymphatic organs of lupus-prone mice |
365 |
| H Iizuka,
T Kubota,
F Satake,
G Hirokawa,
K Miura,
Y Kurosawa,
N Miyasaka & Y Kanai
|
|
Abstract
Full Article (PDF)
|
|
| Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus |
371 |
| M Mosca,
A Pasquariello,
A Tavoni,
L Moriconi,
I Moneta,
M Innocenti,
W Bencivelli & S Bombardieri
|
|
Abstract
Full Article (PDF)
|
|
| Correlation between CD29 density on CD8+ lymphocytes and serum IgG in systemic lupus erythematosus |
379 |
| M Pallis,
KL Lim,
JM Gardner-Medwin,
RA Robins & RJ Powell
|
|
Abstract
Full Article (PDF)
|
|
| Methotrexate use in systemic lupus erythematosus |
385 |
| Y Kipen,
GO Littlejohn & EF Morand
|
|
Abstract
Full Article (PDF)
|
|
| IgA deficiency and SLE: prevalence in a clinic population and a review of the literature |
390 |
| ECC Rankin & DA Isenberg
|
|
Abstract
Full Article (PDF)
|
|
| Immunologically restricted and inhibitory anti-Ro/SSA in monozygotic twins |
395 |
| RH Scofield,
BT Kurien & M Reichlin
|
|
Abstract
Full Article (PDF)
|
|
| The Prevalence of Systemic Lupus Erythematosus in Northern Ireland |
399 |
| IS Gourley,
CC Patterson & AL Bell
|
|
Abstract
Full Article (PDF)
|
|
Case Reports |
| Mycotic aneurysm of a coronary artery in SLE–a rare complication of salmonella infection |
404 |
| HS Howe,
JSL Wong,
ZP Ding,
C Sivathasan,
B Ang,
WH Koh & PH Feng
|
|
Abstract
Full Article (PDF)
|
|
| Successful treatment of early secondary myelofibrosis in SLE with IVIG |
408 |
| A Aharon,
Y Levy,
Y Bar-Dayan,
A Afek,
G. Zandman-Goddard,
Y. Skurnik,
F Fabrrizzi & Y Shoenfeld
|
|
Abstract
Full Article (PDF)
|
|
| Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy |
412 |
| FJ Muñoz-Rodríguez,
J Font,
JR Badia,
C Miret,
JA Barberà,
R Cervera & M Ingelmo
|
|
Abstract
Full Article (PDF)
|
|
Letter to the Editor |
| Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus |
415 |
| O De Pità,
AM Bellucci,
M Ruffelli,
CR Girardelli & P Puddu
|
|
Full Article (PDF)
|
|